We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Q BioMed Announces Strontium89 Initial Uptake and Momentum in US and EuropeSeveral International Market Authorisations Expected in Q4 Expanding Access to South and Central America and...
Q BioMed Announces Initiation of GMP Production of Novel COVID-19 Therapeutic for Clinical Trial Program COVID-19 clinical trial planned for Q1 2021 supported by Canadian...
Q BioMed Announces Strontium89 will be available as of September 2020 through Named Patient Program for Bone Metastases Pain Palliation in EU and Rest of World Named Patient...
FORT LEE, NJ -- March 19, 2019 -- InvestorsHub NewsWire -- GD Entertainment And Technology (OTC: GDET) (“GDET” or the “Company”) today announced CEO Anil Idnani was...
Four Trending Stocks Leading Biotech Sector on Heels of Latest R&D and Innovative Drug Therapy Advancements Coral Springs, FL -- July 27, 2016 -- InvestorsHub...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -9.9E-5 | -99 | 0.0001 | 0.0001 | 1.0E-6 | 156851 | 9.75E-5 | CS |
4 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 176199 | 9.421E-5 | CS |
12 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 175707 | 9.619E-5 | CS |
26 | -9.9E-5 | -99 | 0.0001 | 0.01 | 1.0E-6 | 110756 | 0.00010274 | CS |
52 | 0 | 0 | 1.0E-6 | 0.0405 | 1.0E-6 | 115380 | 0.00028689 | CS |
156 | -0.451999 | -99.9997787611 | 0.452 | 0.66 | 1.0E-6 | 641121 | 0.03043491 | CS |
260 | -1.679999 | -99.9999404762 | 1.68 | 3.75 | 1.0E-6 | 391474 | 0.18574879 | CS |
Symbol | Price | Vol. |
---|---|---|
AITXArtificial Intelligence Technology Solutions Inc (PK) | US$ 0.00275 (0.00%) | 51.06M |
GTEHGenTech Holdings Inc (CE) | US$ 0.000001 (0.00%) | 48.25M |
HMBLHUMBL Inc (PK) | US$ 0.0002 (-33.33%) | 42.65M |
CBGLCannabis Global Inc (PK) | US$ 0.00015 (50.00%) | 41.81M |
GTVHGolden Triangle Ventures Inc (PK) | US$ 0.0008 (33.33%) | 41.61M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions